You are here
Section 14 consents
Medicines and other therapeutic goods must comply with applicable standards to be supplied in Australia.
Under the Therapeutic Goods Act 1989 prior consent must be given under sections 14 and 14A of the Act to the import, export or supply of therapeutic goods that do not comply with an applicable standard. The Secretary can impose conditions on the consent under section 15 of the Act.
The records below include information about these decisions, and any subsequent review of such decisions. All records below which relate to a single consent decision will have the same consent number.
Information about decisions made before 29 January 2016 are on the Federal Register of Legislation website.
For guidance on applying for consent see Consent to import, supply or export therapeutic goods that do not comply with standards - information for industry
In July 2020, TGA created a special consent process for prescription medicine manufacturers experiencing difficulties in introducing new TGO91 labels into their manufacturing process due to COVID-19. These decisions are displayed in a separate database: Database of consents for prescription medicines that do not comply with TGO 91 labelling due to COVID-19.
Filter results
You can narrow down the results using the filters.
Therapeutic good type
- Prescription medicines (2257)
- Listed complementary medicines (2231)
- Over-the-counter medicines (601)
- Blood, tissues, and biologicals (169)
- Registered complementary medicines (141)
- Other therapeutic goods non-approved (44)
- Other therapeutic goods listed (7)
- Other therapeutic goods registered (4)
- Listed Medicines (1)
Search
- CIALIS tadalafil 10mg tablet blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- CIALIS tadalafil 20mg tablet blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- CIALIS tadalafil 5 mg tablet blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- EVISTA raloxifene hydrochloride 60mg tablet blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- FORTEO teriparatide (rbe) 250 microgram solution for injection cartridge, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- HUMALOG insulin lispro 100 IU/mL injection multidose cartridge, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- HUMALOG MIX50 insulin lispro 100 IU/mL injection multidose cartridge, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- PROZAC 20 fluoxetine 20mg (as hydrochloride) capsule blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- Strepsils Herbal Immune Support Lozenge - Elderberry Flavour, INNOVATIVE PHARMA PTY LTD, CON-1241Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 20 May 2024 until 20 November 2024.
- Strepsils Herbal Immune Support Lozenge - Honey Lemon Flavour, INNOVATIVE PHARMA PTY LTD, CON-1241Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 20 May 2024 until 20 November 2024.
- TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- VERZENIO abemaciclib 150 mg tablet blister pack, Eli Lilly Australia Pty Ltd, CON-1240Section 14 consentConsent to import, supply, and export while noncompliant with standards. The consent is effective from 20 May 2024 until 31 March 2025.
- MAXALT MIGRAINE RELIEF rizatriptan 5 mg (as benzoate) wafer blister pack, ORGANON PHARMA PTY LTD, CON-1239Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 16 May 2024 until 31 December 2024.
- COMBIGAN brimonidine tartrate 2.0mg/mL and timolol 5.0mg/mL eye drops bottle, Abbvie Pty Ltd, CON-1238Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 15 May 2024 until 15 May 2025.
- ENIDIN brimonidine tartrate 2mg/mL eye drop bottle, Abbvie Pty Ltd, CON-1238Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 15 May 2024 until 15 May 2025.
- PREDNEFRIN FORTE phenylephrine hydrochloride/prednisolone acetate eye drops bottle, Abbvie Pty Ltd, CON-1237Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 15 May 2024 until 14 May 2025.
- ALLMERCAP mercaptopurine monohydrate 20mg/mL oral liquid suspension bottle, Link Medical Products Pty Ltd T A Link Pharmaceuticals, CON-1236Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 10 May 2024 until 28 February 2025.
- APOMINE Intermittent apomorphine hydrochloride hemihydrate 30mg/3mL injection cartridge, Interpharma Pty Ltd, CON-1235Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 10 May 2024 until 31 December 2024.
- ALBALON naphazoline hydrochloride 1mg/mL eye drop bottle, Abbvie Pty Ltd, CON-1232Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 1 May 2024 until 30 April 2025.
- ALBALON-A eye drop bottle, AbbVie Pty Ltd, CON-1233Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 1 May 2024 until 30 April 2025.
- DEXAMETHASONE VIATRIS dexamethasone phosphate (as dexamethasone sodium phosphate) 4mg/1mL solution for injection vial, Alphapharm Pty Ltd, CON-1234Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 24 April 2024 until 30 April 2025.
- DEXAMETHASONE VIATRIS dexamethasone phosphate (as dexamethasone sodium phosphate) 8mg/2mL solution for injection vial, Alphapharm Pty Ltd, CON-1234Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 24 April 2024 until 30 April 2025.
- ACULAR ketorolac trometamol 5mg/mL eye drop bottle, Abbvie Pty Ltd, CON-1231Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 23 April 2024 until 1 May 2025.
- ALPHAGAN brimonidine tartrate 2mg/mL eye drop bottle, Abbvie Pty Ltd, CON-1231Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 23 April 2024 until 1 May 2025.
- ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle, Abbvie Pty Ltd, CON-1231Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 23 April 2024 until 1 May 2025.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »